Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A model for estimating individualized valproate clearance values in children

J H Botha1, A L Gray, R Miller

  • 1Department of Clinical and Experimental Pharmacology, University of Natal, South Africa.

Journal of Clinical Pharmacology
|October 1, 1995
PubMed
Summary

Population pharmacokinetics of valproic acid in children were evaluated. Valproic acid clearance decreased with age, and was higher with carbamazepine, impacting epilepsy treatment dosing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tonsillitis from the Standpoint of the General Practitioner.

Atlanta journal-record of medicine·2022
Same author

Meta-analytic magic, ivermectin, and socially responsible reporting.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Essential medicine selection during the COVID-19 pandemic: Enabling access in uncharted territory.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Nocturnal Erythromelalgia.

The Physician and sportsmedicine·2016
Same author

Sex differences in glutamate receptor gene expression in major depression and suicide.

Molecular psychiatry·2015
Same author

Sex differences in glutamate receptor gene expression in major depression and suicide.

Molecular psychiatry·2015

Area of Science:

  • Pharmacokinetics
  • Pediatric Epilepsy
  • Drug Metabolism

Background:

  • Valproic acid is a common antiepileptic drug in children.
  • Understanding its population pharmacokinetics is crucial for optimizing therapeutic drug monitoring.
  • Concomitant medications can influence valproic acid levels.

Purpose of the Study:

  • To characterize the population pharmacokinetics of valproic acid in pediatric epilepsy patients.
  • To identify factors influencing valproic acid clearance, such as weight, age, and co-medications.

Main Methods:

  • Utilized 97 steady-state serum valproate concentrations from 52 children (1.2-16 years).
  • Employed a one-compartment model fitted with the Nonlinear Mixed Effects Model (NONMEM).
  • Analyzed data from patients on valproate monotherapy and those with concomitant antiepileptic drugs.

Related Experiment Videos

Main Results:

  • Valproic acid clearance (CL) was modeled as CL = [EXP(0.022WT-1.38)] x M, where WT is weight and M is a medication scaling factor.
  • M was 1 for monotherapy and 1.61 for carbamazepine; phenytoin and phenobarbitone effects were not statistically significant.
  • Weight-adjusted valproate clearance decreased with increasing age.

Conclusions:

  • Pediatric valproic acid clearance is influenced by weight, age, and carbamazepine co-administration.
  • The findings provide valuable data for refining valproic acid dosing strategies in children.
  • Further studies are needed to confirm the impact of phenytoin and phenobarbitone on valproic acid clearance.